Home / Stocks / PARMAX
Back to all stocks
BSE · PARMAX

Parmax Pharma Limited (PARMAX) Share Price

Sector: Healthcare · ISIN: INE240T01014

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,456
of 5,047 stocks
▼ 131W▼ 211M
Peak #3,383 · 02 Oct 2026

A microcap name in Healthcare, Parmax Pharma Limited is growing revenue rapidly, generates a high return on equity, and remains firmly promoter-controlled, with promoters holding 65%. Ownership as of Jun 2026.

Market Cap
50.54 Cr
P/E Ratio
—
P/B Ratio
—
ROE
67.65%
ROCE
-85.76%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q4 2025-26Q3 2025-26Q2 2025-26
Revenue8.22 Cr3.31 Cr4.33 Cr2.53 Cr
Net Profit2.20 Cr-58.43 L-73.20 L-2.08 Cr
EPS5.88-1.56-1.96-5.56
Operating Profit2.43 Cr-1.80 Cr-45.67 L-1.85 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
64.66%
Public
35.34%

PUBLIC BREAKDOWN

Individuals
34.81%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs